Prospective study of Klebsiella pneumoniae bacteremia:<br /> Risk factors and clinical significance of type VIM-1 metallo-beta-lactamases
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2009, Vol 26, Issue 3
Abstract
OBJECTIVE VIM-1-producing K. pneumoniae (VPKP) is an emerging pathogen causing life-threatening infections. This study was conducted to identify the factors associated with bloodstream infections (BSI) caused by VPKP and to evaluate the importance of VIM production on outcome. METHOD A prospective observational study was conducted in three tertiary care hospitals located in Athens, Greece, from 2004 to 2006. Consecutive patients with K. pneumoniae BSI were identified and monitored until discharge or death. Pertinent information was abstracted in a predesigned form. Antimicrobial susceptibility testing was performed by Etest. Microbial characteristics, including MBL production, blaVIM gene carriage and chromosomal types were examined. The data were analyzed to assess for risk factors associated with VPKP BSIs and 14-day mortality. RESULTS A total of 178 patients with Klebsiella pneumoniae BSIs were identified; 67 (37.6%) were infected with a VPKP and 111 with a non-VPKP. MICs of imipenem for VPKP varied from the susceptible range to high-level resistance; 19 isolates were resistant to imipenem and 48 susceptible, whereas none of the non-VPKP exhibited resistance to carbapenems. VPKP were invariably multi-drug resistant. Prior use of carbapenems (OR 4.14; 95% CI 1.75-9.81; P=0.001) and stay in an intensive care unit (ICU) (OR 9.32; 95% CI 3.91-22.20; P<0.01) were independently associated with VPKP BSIs. Overall, patients infected with a VPKP had mortality rates similar to those infected with a non-VPKP. MIC of imipenem >4 μg/mL (OR 4.27; 95% CI 1.41-12.95; P=0.01), older age (OR 1.03; 95% CI 1.00-1.05; P=0.03) and rapidly fatal underlying disease (OR 3.15; 95% CI 1.23-8.04; P=0.016) were independently associated with 14-day mortality. CONCLUSIONS VPKP have spread widely in Greece and cause life-threatening infections, mainly in ICU patients who have had prior exposure to carbapenems. VPKP BSIs are associated with high mortality rates when the infecting organism is resistant to carbapenems.
Authors and Affiliations
P. PETRIKKOS, C. KOSMIDIS, L. TZOUVELEKIS, A. AVLAMIS, I. STEFANOU, E. PLATSOUKA, O. PANIARA, M. TOUTOUZA, K. GEORGOUSI, G. PETRIKKOS
Keywords
Related Articles
- EP ID EP113172
- DOI -
- Views 105
- Downloads 0
The hepatopulmonary syndrome: Current trends
Lung complications may occur as a result of hepatic disease from any cause and they represent a highly heterogeneous group of conditions. The hepatopulmonary syndrome (HPS) is characterized as the triad of liver disease,...
A case of neurosarcoidosis presenting as Guillain-Barré syndrome
Neurosarcoidosis is a rare clinical manifestation of sarcoidosis of unknown origin which often presents diagnostic problems due to a plethora of non-pathognomonic findings in spite of diagnostic and imaging evidence. The...
Solitary rectal ulcer syndrome
No abstract available
Lipoproteins and atherosclerosis
The lipoproteins constitute valuable clinical diagnostic tools. This review will highlight the key clinical diagnostic aspects of the lipoprotein system at the phenotypic level, with the main focus on the following topic...
Hereditary angioedema
No abstract available